The absence of voiding symptoms in men with a PSA ≥ 3.0 ng / mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial

Схожие документы

• Prostate Cancer Risk Assessment in Men with an Initial PSA below 3 ng/mL: Results from the Göteborg Randomized Population-based Prostate Cancer Screening Trial
  по: Frånlund, Maria, et al.
  Опубликовано: (2018)
• The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
  по: Adegun, Patrick Temi, et al.
  Опубликовано: (2015)
• PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml(-1) and 10.1–20.0 ng ml(-1): a multicenter study
  по: Lin, Yu-Rong, et al.
  Опубликовано: (2015)
• Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL
  по: Bolduc, Stéphane, et al.
  Опубликовано: (2007)
• A Multi-Center Study of [−2]Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/mL PSA Range
  по: Catalona, William J., et al.
  Опубликовано: (2011)